Lapam Capital

Portfolio Co Investors 2026 for Lapam Capital: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.

Lapam Capital accounts for 8 tracked companies with verified cap-table data, 8 of which disclose round sizes totalling $528M. The median disclosed raise is $55M, and the largest is Enchannel at $110M, ahead of Epigenic Therapeutics ($92M) and Allink Biotherapeutics ($89M).

The names that recur most often on these co-invested cap tables are Lapam Capital (8 companies), BioTrack Capital (3 companies), Yonjin Capital (3 companies), 3E Bioventures Capital (3 companies), Proxima Ventures Ltd. (3 companies), 5Y Capital (2 companies). By latest disclosed round, the market skews Series A (4), Series B (3), Seed (1).

Best funded Lapam Capital companies

  1. Enchannel — $110M (latest: Series B)
  2. Epigenic Therapeutics — $92M (latest: Series B)
  3. Allink Biotherapeutics — $89M (latest: Series A)
  4. ReviR Therapeutics — $55M (latest: Seed)
  5. Ranok Therapeutics — $50M (latest: Series B)
  6. Rapafusyn Pharmaceuticals — $44M (latest: Series A)
  7. Senxuan — $44M (latest: Series A)
  8. Bodyfriend — $44M (latest: Series A)

Lapam Capital — related firms and companies (51)

Lapam Capital alternatives · All research reports